Literature DB >> 18283781

Primary myelofibrosis.

Ayalew Tefferi1.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18283781

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  5 in total

Review 1.  Therapy of myelofibrosis (excluding JAK2 inhibitors).

Authors:  Alessandro Rambaldi
Journal:  Int J Hematol       Date:  2010-02-24       Impact factor: 2.490

2.  Pathological interactions between hematopoietic stem cells and their niche revealed by mouse models of primary myelofibrosis.

Authors:  Lilian Varricchio; Annalisa Mancini; Anna Rita Migliaccio
Journal:  Expert Rev Hematol       Date:  2009-06-01       Impact factor: 2.929

3.  A novel population of cells expressing both hematopoietic and mesenchymal markers is present in the normal adult bone marrow and is augmented in a murine model of marrow fibrosis.

Authors:  Masanobu Ohishi; Wanida Ono; Noriaki Ono; Richa Khatri; Marilena Marzia; Emma K Baker; Sierra H Root; Tremika Le-Shan Wilson; Yukihide Iwamoto; Henry M Kronenberg; Hector L Aguila; Louise E Purton; Ernestina Schipani
Journal:  Am J Pathol       Date:  2011-12-05       Impact factor: 4.307

Review 4.  Fibrogenesis in Primary Myelofibrosis: Diagnostic, Clinical, and Therapeutic Implications.

Authors:  Aziz Nazha; Joseph D Khoury; Raajit K Rampal; Naval Daver
Journal:  Oncologist       Date:  2015-08-24

Review 5.  Epigenetic therapy in myeloproliferative neoplasms: evidence and perspectives.

Authors:  Alessandro M Vannucchi; Paola Guglielmelli; Alessandro Rambaldi; Costanza Bogani; Tiziano Barbui
Journal:  J Cell Mol Med       Date:  2009-06-11       Impact factor: 5.310
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.